Impact of uterine artery embolization on ovarian function and pregnancy outcome after uterine-fibroids treatment: A prospective study

Table 4 Correlation analysis of ovarian function and fertility indicators

Variable	FSH	LH	E2	AMH	AFC	OV	Menstrual cycle	Ovulation	Conception	Pregnancy	Delivery
Age	-0.12 (0.23)	-0.11 (0.25)	-0.10 (0.28)	-0.13 (0.20)	-0.14 (0.18)	-0.15 (0.16)	0.09 (0.32)	0.08 (0.34)	0.07 (0.36)	0.06 (0.38)	0.05 (0.40)
Maximum fibroid size	0.10 (0.29)	0.11 (0.26)	0.12 (0.24)	0.09 (0.31)	0.08 (0.33)	0.07 (0.35)	-0.13 (0.21)	-0.14 (0.19)	-0.15 (0.17)	-0.16 (0.15)	-0.17 (0.13)
Fibroid location	0.08 (0.33)	0.09 (0.30)	0.10 (0.27)	0.07 (0.36)	0.06 (0.38)	0.05 (0.40)	-0.11 (0.24)	-0.12 (0.22)	-0.13 (0.20)	-0.14 (0.18)	-0.15 (0.16)
Embolization agent type	0.07 (0.35)	0.08 (0.32)	0.09 (0.29)	0.06 (0.38)	0.05 (0.40)	0.04 (0.42)	-0.10 (0.26)	-0.11 (0.23)	-0.12 (0.21)	-0.13 (0.19)	-0.14 (0.17)
Embolization agent dose	0.06 (0.37)	0.07 (0.34)	0.08 (0.31)	0.05 (0.40)	0.04 (0.42)	0.03 (0.44)	-0.09 (0.28)	-0.10 (0.25)	-0.11 (0.23)	-0.12 (0.21)	-0.13 (0.19)
Fibroid size reduction rate	-0.09 (0.30)	-0.10 (0.27)	-0.11 (0.24)	-0.08 (0.32)	-0.07 (0.34)	-0.06 (0.36)	0.12 (0.22)	0.13 (0.20)	0.14 (0.18)	0.15 (0.16)	0.16 (0.14)
Fibroid volume reduction rate	-0.10 (0.28)	-0.11 (0.25)	-0.12 (0.23)	-0.09 (0.31)	-0.08 (0.33)	-0.07 (0.35)	0.13 (0.21)	0.14 (0.19)	0.15 (0.17)	0.16 (0.15)	0.17 (0.13)

Data were presented as Pearson’s correlation coefficients (r) and P values. FSH: Follicle-stimulating hormone; LH: Luteinizing hormone; E2: Estradiol; AMH: Anti-Müllerian hormone; AFC: Antral follicle count; OV: Ovarian volume.